Indications et résultats de la nutrition artificielle à domicile chez le patient cancéreux

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Peut-on améliorer les apports énergétiques et protéiques de patients gériatriques hospitalisés sans ajouts de suppléments nutritionnels

info:eu-repo/semantics/publishe

Hypovitaminosis D In Old Patients: Role Of Dietary Intakes

info:eu-repo/semantics/publishe

Can inpatients geriatric consultation services use the malnutrition screening tool (MUST) to screen the risk of malnutrition

info:eu-repo/semantics/publishe

Lessons from a 20 year experience of Home Parenteral Nutrition in adult patients

Background: Home Parenteral Nutrition (HPN) is a method commonly used in patients with Chronic Intestinal Failure (CII) related to benign or malignant diseases. We report the experience from a 20 year programme of HPN in a single academic centre. Methods: In this study, we have reviewed characteristics and outcome of a group of patients enrolled in a HPN program between 1987 and 2007. Focus was given to the prevalence and severity of cholestasis in these patients as well as on their oral food behaviour. Results: In 20 years, 125 patients were included in a HPN programme; 65 patients had benign diseases (BD) and 60 advanced cancer (AC). Short bowel was the most common indications in patients with BD. Almost 40% of patients with BD were weaned off HPN. Median survival was excellent in BD patients and extremely short in AC. Death related to HPN was very rare. Cholestasis has been observed in 84% of patients but it was mild to moderate in the majority of cases. Hyperphagia was observed in 50% of the patients with BD on long-term HPN. Conclusions: This study confirms that HPN is the first line therapy in CII due to BD. Patients with AC should be carefully selected. Cholestasis is frequent but mostly without clinical impact. Half of the patients with CII due to BD become hyperphagic allowing to reduction of parenteral intake. The role of a multi - disciplinary nutrition support team is essential for optimizing HPN. (Acta gastro enterol. belg. 2010, 73, 451-456).SCOPUS: re.jinfo:eu-repo/semantics/publishe

Facteurs cliniques et biologiques de mortalité précoce chez des patients atteints de cancer

Société Francophone de Nutrition Clinique et Metabolismeinfo:eu-repo/semantics/publishe

Prevalence of starvation or cachexia at early diagnosis of cancer patients

info:eu-repo/semantics/publishe

Prevalence of starvation or cachexia at early diagnosis of cancer patients

info:eu-repo/semantics/nonPublishe

Home enteral nutrition in adults: A European multicentre survey

Aims: This study was undertaken to report indications and practice of home enteral nutrition (HEN) in Europe. Methods: A questionnaire on HEN practice was sent to 23 centres from Belgium (B), Denmark (D), France (F), Germany (G), Italy (I), Poland (P), Spain (S) and the United Kingdom (UK). This involved adult patients newly registered in HEN programme from 1 January 1998 to 31 December 1998. Results: A total of 1397 patients (532 women, 865 men) were registered.The median incidence of HEN was 163 patients/million inhabitants/year (range: 62-457). Age distribution was 7.5%,16-40 years; 37.1%,41-65 years; 34.5%, 66-80 years and 20.9% > 80 years. The chief underlying diseases were a neurological disorder (49.1%), or head and neck cancer (26.5%); the main reason for HEN was dysphagia (84.6%). A percutaneous endoscopic gastrostomy (58.2%) or a naso-gastric tube (29.3%) were used to infuse commercial standard or high energy diets (65.3%), or fibre diets (24.5%); infusion was cyclical (61.5%) or bolus (34.1%). Indications and feeds were quite similar throughout the different centres but some differences exist concerning the underlying disease. There was greater variation in the choice of tubes and mode of infusion. In F, G, I, S, and UK, costs of HEN are fully funded. In B, D, and P patients have to pay part or all of the charges. Conclusions: In Europe, HEN was utilised mainly in dysphagic patients with neurological disorders or cancer, using a standard feed via a PEG. However, there were important differences among the countries in the underlying diseases treated, the routes used, the mode of administration and the funding. © 2003 Elsevier Science Ltd. All rights reserved.SCOPUS: ar.jinfo:eu-repo/semantics/publishe